CHDI Inc. will be hosting the 3rd annual Huntington Disease Therapeutics Conference on February 4-7 in Palm Springs, California. Though they have have graciously extended an invitiation to Huntington families in the local area, this conference is quite technical, fast-paced, and intended mainly for researchers and drug company officials. If you would like to come, please contact Jerry Turner at This email address is being protected from spambots. You need JavaScript enabled to view it. so that CHDI can expect you as a visitor. The final day will be more relevant for Huntington families.

Extracted from the tentative schedule supplied by High Q/CHDI:

3rd Annual HD Therapeutics Conference: A Forum for Drug Discovery & Development~ TENTATIVE PROGRAM ~

Monday, February 4th, 2008

5:00pm - 5:15pm Introduction: Robert Pacifici, PhD - CHDI

5:15pm - 6:00pm Historical Perspective: Allan Tobin, PhD - CHDI

6:00pm - 7:00pm Keynote Speaker: Charles Sabine - NBC News Correspondent

Tuesday, February 5th, 2008

9:00am - 12:20pm Identification of Therapeutic Targets for HD

Chaired by Seung Kwak, PhD & Deanna Marchionini, PhD - CHDI


2:00pm - 5:20pm Translation and Prosecution

Chaired by Leticia Toledo-Sherman, PhD & Jim Wang, PhD - CHDI


Wednesday, February 6th, 2008

9:00am - 12:20pm Validating Assays: Bridging the Gap Between In Vitro

and In Vivo

Chaired by Vahri Beaumont, PhD & John Wityak, PhD - CHDI


4:00pm - 5:00pm Featured Speaker (To be Announced)

5:00pm - 7:00pm Formal Poster Session -

Thursday, February 7th, 2008

9:00am - 12:20pm Pre-Clinical Efficacy

Chaired by David Howland, PhD & Janet Leeds, PhD - CHDI


2:00pm - 5:20pm Clinical Development and the Use of Biomarkers in HD

Chaired by Beth Borowsky, PhD & Dan van Kammen, MD, PhD - CHDI


5:20pm - 5:35pm Closing Remarks: Robert Pacifici, PhD - CHDI